Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
USA v. Babich et al
Case Number:
1:16-cr-10343
Court:
Nature of Suit:
Judge:
Firms
- Brown Rudnick
- Clark Hill
- Donnelly Conroy
- Fick & Marx
- Fitch Law Partners
- Hogan Lovells
- King & Spalding
- Kobre & Kim
- Miner Siddall
- Mitchell Stein Carey
- Morgan Lewis
- Nixon Peabody
- Ropes & Gray
- Weil Gotshal
- White & Case
- Wilkinson Stekloff
Companies
Sectors & Industries:
-
July 24, 2018
Feds Try To Clear Up Ex-Insys Execs' RICO Charge For Judge
After a contentious hearing last week, federal prosecutors charging several former Insys Therapeutics Inc. executives with conspiring to bribe doctors so they'd prescribe the company's fentanyl spray tried to explain the racketeering charges to a puzzled Massachusetts federal judge and promised a new, streamlined indictment in a memorandum filed Tuesday morning.
-
July 17, 2018
RICO Indictment Against Ex-Insys Execs Perplexes Judge
A Massachusetts federal judge on Tuesday appeared befuddled by the government's Racketeer Influenced and Corrupt Organizations Act indictment charging former Insys Therapeutics Inc. executives with multiple schemes to bribe doctors to prescribe the company's pricey fentanyl spray, saying the allegations are confusing and fail to establish a common link in the alleged conspiracy.
-
June 12, 2018
Ex-Insys Execs Can't Get More Info On Charges, Feds Say
Federal prosecutors late Monday blasted an attempt by former executives at Insys Therapeutics Inc. to get more details about charges that they bribed doctors to boost sales of their fentanyl spray, saying the executives have more than enough information from the complaint and discovery.
-
May 22, 2018
Ex-Insys Execs Rail Against 'Inflammatory' RICO Indictment
Former executives at Insys Therapeutics Inc. blasted "inflammatory" drug-enterprise charges against them on Monday in a bid to dismiss a lengthy indictment claiming they bribed doctors to prescribe the company's expensive fentanyl spray, calling the allegations "ugly insinuations about lawful business practices."
-
January 18, 2018
Prosecutor Flustered By Surprise Motions At Insys Hearing
Former executives at Insys Therapeutics Inc. charged with plotting to bribe fentanyl prescribers notched a quick win on evidence access Thursday at a Boston hearing that grew tense after defense counsel surprised a leading federal prosecutor with last-minute motions.
-
January 01, 2018
Massachusetts Cases To Watch In 2018
The year ahead promises to bring several high-profile cases to Massachusetts as the office of newly appointed U.S. Attorney Andrew Lelling gets ready to try consequential matters involving public corruption and the opioid crisis, while the U.S. Supreme Court considers petitions over a Native American tribe's bid to bring casino gambling to Martha's Vineyard.
-
November 16, 2017
Insys Founder Denies Plot To Bribe Doctors Over Opioid Spray
Insys Therapeutics Inc. founder John N. Kapoor pled not guilty on Thursday to orchestrating a national scheme to bribe doctors to needlessly prescribe his company's unique and powerful opioid painkiller that is sprayed under the tongue.
-
October 31, 2017
Insys Founder Resigns From Board After Opioid Charges
John N. Kapoor, the founder of Insys Therapeutics Inc., has resigned from the company's board of directors after he was charged with racketeering and fraud for allegedly bribing doctors who prescribed a spray version of the opioid fentanyl to patients who didn't necessarily have cancer pain.
-
October 26, 2017
Insys Founder Charged With Racketeering In Opioid Scheme
John Kapoor, the founder and chairman of scandal-wracked Insys Therapeutics Inc., was arrested and charged with racketeering and fraud on Thursday for allegedly bribing doctors to prescribe a powerful fentanyl-based painkiller for off-label uses, joining six other Insys officials who have been charged.
-
September 12, 2017
Indicted Insys Execs Face October 2018 Trial
A Massachusetts federal judge on Tuesday set an Oct. 15, 2018, trial date for six former Insys Therapeutics Inc. executives and managers accused of bribing doctors to prescribe a spray version of the opioid fentanyl intended to treat cancer pain, often to patients without cancer.